Loading clinical trials...
Loading clinical trials...
This study evaluates the accuracy of artificial intelligence (AI) models using FibroScan and clinical data to predict hepatic fibrosis in Egyptian patients with metabolic-associated fatty liver diseas...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tanta University
NCT07087418 · Digestive Diseases, Radiology, and more
NCT07068191 · Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly, and more
NCT07471984 · Central Nervous System Disease, MRI, and more
NCT07167043 · Central Nervous System Disease, MRI, and more
NCT06951152 · AI (Artificial Intelligence)
Faculty of Medicine
Tanta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions